Intas Intacef Tazo 562.5mg Injection | Cefepime 500mg & Tazobactam 62.5mg (1 Vial)
Intas Intacef Tazo is a broad-spectrum injectable antibiotic combining Cefepime 500mg (fourth-generation cephalosporin) and Tazobactam 62.5mg (beta-lactamase inhibitor). Tazobactam protects Cefepime from bacterial beta-lactamase enzymes, extending its antibacterial spectrum against resistant gram-positive and gram-negative bacteria.
Note: verify exact indications and species suitability from the product label or package insert.
Composition (Per Vial)
- Cefepime: 500mg — fourth-generation cephalosporin; broad-spectrum bactericidal cephalosporin antibiotic
- Tazobactam: 62.5mg — beta-lactamase inhibitor; protects Cefepime from enzymatic degradation by resistant bacteria
Key Benefits
- Broad-spectrum antibacterial coverage against gram-positive and gram-negative pathogens
- Tazobactam extends efficacy against beta-lactamase-producing resistant strains
- Fourth-generation cephalosporin — effective against a wide range of susceptible organisms
- Injectable vial format for parenteral administration
Indications
- Respiratory tract infections caused by susceptible bacteria
- Urinary tract infections caused by susceptible gram-negative organisms
- Skin and soft tissue infections
- Intra-abdominal infections
- Serious and complicated bacterial infections caused by resistant organisms
Dosage & Administration
- Administer parenterally as directed — dose and duration based on species, body weight, and severity of infection
- For parenteral (IV/IM) use only — administer under veterinary supervision
- Complete the full prescribed course
Safety Information
- Prescription-only medication — use strictly under veterinary supervision
- Use with caution in animals with known renal impairment
- Not effective against viral infections
- Keep out of reach of children
- Store in a cool, dry place away from direct sunlight